<DOC>
	<DOCNO>NCT00844363</DOCNO>
	<brief_summary>Ultra-violet light B ( UVB ) therapy use dermatologist treat psoriasis decade . Only study begin dissect mechanism NB-UVB therapy cause lesion resolution . Results study aid identifying disease may treat successfully NB-UVB . If identify mechanism action therapy , may give u additional new therapeutic target psoriasis disease . Our overall hypothesis UVB induces change indicate mechanism action therapy psoriasis .</brief_summary>
	<brief_title>Narrowband UVB Phototherapy Treatment Psoriasis Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Signed informed consent . History chronic plaque psoriasis vulgaris , least six month . â‰¥10 % body surface affect Age 18 great . Concomitant , chronic , wellcontrolled medical condition hypertension allowable . No treatment topical steroid least 2 week prior enter study No treatment systemic therapy , include etretinate , UVB , PUVA , cyclosporine , biologics 4 week prior enter study . However , patient consider `` unstable '' , would deteriorate clinically systemic agent cease ( eg efalizumab ) , short `` washout '' period may consider , would document patient chart . Patients receive stable dose methotrexate ( define &lt; 15mg/week 4 month great ) psoriatic arthritis may include . Subjects meet criterion , meet follow criterion : Guttate , erythrodermic , pustular psoriasis sole predominant form psoriasis . PHOTOSENSITIVITY : Hypersensitivity sunlight UVB light type ; history Lupus , PMLE , disease know worsened UV light exposure A history nonmelanoma skin cancer may acceptable , situation , patient carefully evaluate . Poorly control medical condition kind . Any medical condition , opinion Investigator , would jeopardize health well patient course study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>